Clinical research is an integral part of developing, testing, and refining new therapies. As one of our Clinical Research Coordinators Vera George is responsible for making sure dozens of these studies at Duke run smoothly and efficiently. For this week’s “Spotlight” interview, George talks to us about the joys of helping current and future patients with myasthenia gravis, movement disorders, and other conditions.
Shruti Raja, MD, MHS, assistant professor of neurology in the Duke University School of Medicine, has been named Faculty Director of the Duke Early Phase Research Unit (DEPRU).
This February, new research from members of the Duke Neurology Department advanced our understanding of the treatment of stroke, brain tumors and amyotrophic lateral sclerosis (ALS) as well as the genetics and origins of Alzheimer’s disease. The 13 journal articles written or co-written by members of our faculty include publications in JAMA, Neurology, the British Medical Journal, and other publications. Read summaries of those studies, and find links to the original articles, in the paragraphs below.
The first month of 2022 saw the publication of 18 new peer-reviewed journal articles from members of the Duke Neurology Department. Highlights include a new article in Lancet Neurology discussing the epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders, case reports describing the progression and treatment options for rare neurological conditions, and a summary of how the first year of the COVID-19 pandemic affects neurology residency programs in the United States.
Research authored by members of the Duke Neurology Department published during the final month of 2021 advanced our knowledge of stroke, epilepsy, dystonia, and other conditions.
Over the course of a few days in late September of 2021, Carol Cerase of Lumberton, NC, experienced increasing weakness in her legs, trouble swallowing, and several falls. Doctors at her local hospital couldn’t find the cause, so they reached out to Duke Health’s neurology experts, who diagnosed Cerase with Guillain-Barré syndrome (GBS). Duke’s team recommended plasma exchange therapy to stop the disease’s progression and allow the nerves to heal. “I was lucky I got the treatment so fast,” said Cerase. “I think it saved me.”
This October, members of the Duke Neurology Department contributed to 12 new peer-reviewed journal articles, advancing our understanding of Alzheimer’s disease, stroke, chronic pain, and other conditions. These articles include discussions of the best framework for neuroscience curricula for medical students, the discovery of an existing experimental drug which offers a new avenue for treating pain without potential addiction issues, and an examination of the viability of ketogenic diets as an alternative treatment for amyotrophic lateral sclerosis (ALS).
Members of the Duke Neurology Department contributed to seventeen peer-reviewed research studies published this August. Members of the lab of Nicole Calakos, MD, PhD, discovered that a medication created to treat patients with HIV may help people with dystonia. New translational research provided the most accurate atlas of the mouse model to date and answered questions about late-onset Alzheimer’s disease.
This July, new research from the Duke Neurology Department answered questions about the subcellular origins of itching, how COVID-19 is affecting people with amyotrophic lateral sclerosis, what factors influence people eligible for epilepsy surgery to move forward with the procedure and topics. The paragraphs below summarize the 11 articles appearing in peer-reviewed publications from our faculty, staff, and trainees. Check them out and find links to the original publications below.
New publications written by members of the Duke Neurology Department published this June advanced our understanding of the origins of Alzheimer’s disease, stroke, and spinal injuries, as well as offering new insights on how to better diagnose and treat these and other conditions. Our faculty contributed to recent articles in Lancet Neurology, Stroke, and other high-impact journals. Read more about each of these stories, and find links to the original articles themselves, in the paragraphs below.